Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Lab_Corp
|
| gptkbp:ceo |
Jonny Mc Culloch
|
| gptkbp:employees |
over 15,000
|
| gptkbp:focus |
gptkb:Company
quality assurance data analytics data integration neurology oncology patient engagement patient recruitment personalized medicine rare diseases real-time data access statistical analysis biostatistics vaccines data management remote monitoring infectious diseases bioequivalence studies clinical trial design medical writing regulatory submissions laboratory services pharmacovigilance safety assessment digital health solutions health economics clinical pharmacology outcomes research metabolic diseases cardiovascular market access services clinical development regulatory consulting genomics services bioanalytical services Phase I-IV clinical trials medical device testing clinical monitoring clinical trial optimization clinical pharmacology studies clinical supply management therapeutic expertise artificial intelligence in drug development investigator sites real world evidence |
| gptkbp:founded |
gptkb:1997
|
| gptkbp:global_presence |
operates in over 60 countries
|
| gptkbp:headquarters |
gptkb:Princeton,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Covance
|
| gptkbp:industry |
pharmaceutical services
|
| gptkbp:parent_company |
gptkb:Lab_Corp
|
| gptkbp:revenue |
$1.5 billion (2020)
|
| gptkbp:services |
drug development
clinical trial management preclinical testing |
| gptkbp:type |
contract research organization
|
| gptkbp:website |
www.covance.com
|
| gptkbp:bfsParent |
gptkb:Sparta_Systems
gptkb:Lab_Corp |
| gptkbp:bfsLayer |
4
|